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In patients with carcinoma of the head of the 
pancreas with positive lymph nodes, the extent of an 
adequate lymph node dissection beyond peripancreatic area 
has remained controversial. Based on the two anlagens, the 
ventral or dorsal pancreas, we assessed the lymphatic 
spread pattern in 58 primary adenocarcinoma of head of the 
pancreas.  Detection of lymph node mestastasis was based 
on microscopic detection of carcinoma in consecutive serial 
sections of resected specimens including lymph nodes. 
When the tumor was confined to the ventral pancreas 
domain (n=20), the lymph node metastases were limited to 
areas along the superior mesenteric artery (SMA) besides 
peripancreatic lymph nodes. When the tumor was in the 
dorsal pancreas domain (n=6), the lymph node metastases 
were limited to areas along the common hepatic artery 
(CHA) and the hepatoduodenal ligament besides 
peripancreatic lymph nodes. When the tumor was extended 
into both domains (n=32), the lymph node metastases were 
distributed widely in areas along the SMA, CHA and the 
hepatoduodenal ligament besides peripancreatic lymph 
nodes. Based on these findings, the lymphatic spread of 
carcinomas of the head of the pancreas can be divided into 
two patterns by tumor location based on the two anlagens 
















Over the past several years, radical resection has 
evolved to be most commonly defined as a wide en bloc 
pancreaticoduodenal resection, incorporating a wide soft 
tissue resection margin including extrapancreatic nerve 
plexuses, combined with the harvest of specific lymph node 
stations and a retroperitoneal lymphadenectomy (1-4). The 
rationale for more extensive surgery was based on the 
observation that a standard operation fails to remove nodal 
groups that even in patients with small neoplasms often are 
involved with microscopic disease. However, dismal 
complications affecting the quality of life, particularly 
disturbances in digestive absorption such as diarrhea, are a 
significant morbidity associated with this type of surgery 
(3, 5). Furthermore, many of those patients who die after a 
potentially curative resection die from local recurrences (6). 
Four prospective randomized trials have compared a 
standard pancreatoduodenectomy versus one with an 
extended lymphadenectomy for patients with potentially 
curative pancreatic head adenocarcinoma (5, 7-9). All were 
unable to detect an improvement in survival with the more 
radical operation. Therefore many surgeons have asked 
how one should treat patients with positive lymph nodes 
and peripancreatic soft tissue invasion. There currently is 
no consensus on what constitutes an adequate lymph node




Figure 1.  The distribution of the ventral and dorsal 
anlagen after fusion. (Suda's original (11)). 
 
dissection and peripancreatic soft-tissue resection, nor how 
extensive a lymph node dissection should be to ensure that 
there is adequate stage assignment. 
 
 The pancreas arises from two anlagen on an 
embryological basis. Both anlagen fuse at about the 6-7th 
fetal week (10). The smaller ventral bud forms the caudal 
part of the pancreatic head and uncinate process, whereas 
the cephalic part of the pancreatic head as well as the body 
and tail are derived from the larger dorsal bud. The 
distribution of the ventral pancreas after fusion is the dorsal 
portion of the head containing the area surrounding the 
intrapancreatic common bile duct and the uncinate process. 
 
We carefully investigated the correlation between 
the pattern of cancer spread and the tumor location in the 
pancreas head microscopically by consecutive serial 
sections of resected specimens. These results were 
compared with multi detector computed tomography (MD-
CT) images. We noticed a spread pattern that could be 
attributed to the tumor location and we speculated that this 
phenomenon is correlated with the embryological structure 
of pancreas. In this study, we analyzed the nodal positivity 
of Group 2 lymph nodes as correlated with tumor location 
based on the two anlagen. 
 
3. MATERIALS AND METHODS 
 
3.1. Patients 
Fifty-eight patients underwent a 
pancreatoduodenectomy as a treatment for invasive ductal 
carcinoma of the pancreas head between 1997 and 2005 at 
the Department of Gastroenterologic Surgery, Kanazawa 
University, Japan. Patients underwent a D2 resection, and 
the anterior and posterior pancreaticoduodenal nodes 
(No.17, No.13), the nodes in the hepatoduodenal ligament 
(No.12), the nodes along the common hepatic artery (CHA) 
(No.8), the nodes along the superior mesenteric artery 
(SMA) (No.14) and the infrapyloric lymph nodes (No.6) 
were harvested en bloc. The portal vein (PV) and/or the 
superior mesenteric vein (SMV) were resected in 45 of 58 
patients undergoing pancreatoduodenectomy. All study 
subjects underwent the resection with curative intent.  
3.2. Histology and immunohistochemical staining 
The resected specimens with the attached 
peripancreatic lymph nodes and nerve plexuses were 
immediately fixed in 10% neutral-buffered formaldehyde 
solution for at least 10 days. After the specimens were cut 
perpendicular to the body axis (similar to the slices in a CT 
scan) in 5-mm tissue blocks, the blocks were embedded in 
paraffin and 5-µm sections were stained with hematoxylin 
and eosin (H/E). Immunohistochemical staining with an 
anti-pancreatic polypeptide (PP) was performed using the 
EnVision+ system (Dako Cytomation, Glostrup, Denmark). 
The sections were deparaffinized and treated with 0.3% 
hydrogen peroxidase for 10 minutes to inactivate 
endogenous peroxidase. They were then washed in 
phosphate-buffered saline for 15 minutes. The sections 
were incubated with a rabbit antibody against human PP 
(diluted 1:600; Dako Cytomation) for 60 minutes at room 
temperature. After washing, the sections were incubated 
with EnVision labeled polymer (Dako) for 60 minutes. 
Finally, the reaction products were developed in a 0.02% 3, 
3' -diaminobenzidine tetrahydrochloride solution (Dako). 
The sections were counterstained with hematoxylin. 
 
3.3. Statistical Analysis 
 Statistical analysis was performed with the chi-




4.1. Tumor location and size 
Differentiation of the ventral and dorsal pancreas 
was determined as described by Suda et al. (Figure 1) (11-
13). The duct of Wirsung, intrapancreatic common bile 
duct, the duct of Santorini, and PV/SMV are available to 
distinguish both; therefore, the area around the duct of 
Wirsung and the intrapancreatic common bile duct is 
commonly derived from the ventral anlagen, while the area 
around the duct of Santorini is derived from the dorsal 
anlagen. Moreover, the PV lies behind the dorsal pancreas 
and the SMV lies forward of the ventral pancreas; 
therefore, the ventral bud rotates backward behind the 
duodenum, and eventually its tip lies behind the SMV. 
Sections perpendicular to the body axis (similar to a CT 
scan) were stained immunohistochemically with anti-PP. 
Stained cells were mainly detected in the ventral pancreas 
(Figure 2A). On the CT scan images, we distinguished the 
ventral and dorsal pancreas using the duct of Santorini, the 
duct of Wirsung, the PV/SMV, and the bile duct as 
landmarks. The head of the pancreas could be divided into 
the dorsal and ventral pancreas by a line linking the PV / 
SMV and the anterior edge of the intrapancreatic bile duct 
(Figure 2B). This corresponded to the differentiation 
between ventral and dorsal pancreas by immunostaining 
with PP. The location of the tumor based on the 
organogenesis of the pancreas was analyzed 
microscopically by consecutive serial sections of the 
resected specimens and compared with the MD-CT images 
with the aid of a pathologist and radiologist. These cases 
were divided three groups as follows, confined to the 
ventral pancreas (V), confined to the dorsal pancreas (D), 
extension into both areas (VD). The maximum diameter of 
the tumor was measured on histological examination. Local




Figure 2.  Distinction of the ventral and dorsal pancreas in the head of pancreas. A: Immunohistochemical staining for pancreatic 
polypeptide in the pancreas head. B: CT images of same slice. After the specimens were cut perpendicular to the body axis 
similar to a CT scan into 5-mm tissue blocks, the sections were stained immunohistochemically with an anti-pancreatic 
polypeptide. Positive staining cells were mainly detected in the ventral pancreas (A).  The duct of Wirsung, the intrapancreatic 
common bile duct, the duct of Santorini, and the superior mesenteric vein are available landmarks to distinguish the ventral from 
dorsal pancreas. On the CT scan image, the head of the pancreas could be divided into the dorsal and the ventral pancreas by a 
red dotted line linking the PV / SMV and the anterior edge of the intrapancreatic bile duct (B). This corresponds to the ventral 
and dorsal pancreas identified by immunostaining with pancreatic polypeptide. GDA: gastroduodenal artery, Duo: duodenum, 
CBD: common bile duct, SMV: superior mesenteric vein, SMA: superior mesenteric artery, DW: duct of Wirsung. 
 
extension was categorized as follows: S: serosal invasion, 
RP: retropancreatic tissue invasion, PVS: portal venous 
system (SMV, PV, and splenic vein) invasion, A: arterial 
system (celiac artery, CHA, SMA, and splenic artery) 
invasion, DU: duodenal invasion, CH: distal bile duct 
invasion, PL: extrapancreatic nerve plexus invasion. 
Nomenclature for nodal station and extrapancreatic neural 
plexuses was based on the Japan Pancreas Society: 
Classification of Pancreatic Carcinoma (second English 
Edition) (14). Group 1 lymph nodes consist of those usually 
removed during a resection of the head of the pancreas and 
include the lymph nodes on the posterior (No.13) and 
anterior (No.17) aspect of the head of the pancreas. Group 
2 and 3 were classified on the basis of lymph flow, rate of 
involvement by metastasis, and outcome. Group 2 lymph 
nodes include the infrapyloric lymph nodes (No.6), the 
lymph nodes along the CHA (No.8), the lymph nodes in the 
hepatoduodenal ligament (No.12), and lymph nodes along 
the SMA (No.14). Group 3 lymph nodes include the lymph 
nodes around the stomach except the infrapyloric lymph 
nodes, the lymph nodes along the left gastric artery, the 
lymph nodes along the celiac artery, the lymph nodes at the 
splenic hilum, the lymph nodes along the splenic artery, the 
lymph nodes along the middle colic artery, and the lymph 
nodes around the abdominal aorta. 
 
A typical case of pancreatic carcinoma confined 
to the ventral pancreas is shown in Figures 3 and 4. Figure 
3 shows the MD-CT images, a weakly enhancing tumor 
(white arrows) is detected behind the SMV, and in front of 
this tumor, the duct of Santorini is intact and not apparently 
invaded by tumor. H/E staining and immunohistochemistry 
for PP of the resected specimen of this patient shows cancer 
localized to the uncinate process of the ventral pancreas 
with extrapancreatic nerve plexus invasion (Figure 4). A 
typical case of pancreatic carcinoma confined to the dorsal 
pancreas is shown in Figures 5 and 6. Figure 5 shows the 
MD-CT images, a weakly enhanced tumor (white arrows) 
extending to the front with occlusion of the main pancreatic 
duct and pressing upon the SMV and intrapancreatic bile 
duct posteriorly. The duct of Wirsung is intact and not 
involved with tumor. H/E staining and 
immunohistochemistry for PP of the resected specimen 
shows cancer localized to the dorsal pancreas with serosal 
invasion (Figure 6). The SMV is pushed posteriorly. 
 
The location of the tumor  based upon embryonic 
origin and the averages of the tumor diameter in the 
patients in this study with pancreatic head carcinoma are 
shown in Table 1. Of the 58 cases of pancreas head 
carcinoma, the tumor was localized to the ventral pancreas 
(V) in 21 cases (36%), localized to the dorsal pancreas (D)




Figure 3.  A case of pancreatic head carcinoma confined to the ventral pancreas.  MD-CT images show a weakly enhancing 




Figure 4.  H/E staining and immunohistochemistry for pancreatic polypeptide of the resected specimen shows cancer limited to 
the uncinate process of the ventral pancreas with extrapancreatic nerve plexus invasion (red arrows). 
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Figure 5.  A case of pancreatic head carcinoma confined to the dorsal pancreas.  MD-CT images show a weakly enhancing tumor 
(white arrows) extend to front side with occlusion of the main pancreatic duct, and press SMV and intrapancreatic bile duct to 




Figure 6.  H/E staining and immunohistochemistry for pancreatic polypeptide of the resected specimen shows cancer limited to 
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Table 1.  Tumor location based upon embryology and the average of the tumor diameter in patients with pancreatic head 
carcinoma 
Location No. (%) Size of Tumor (mm) (mean ± SD) 
Ventral (V) 21 (36%) 32 ± 13 
Dorsal (D) 6 (10%) 35 ± 8 
Both areas (VD) 31 (54%) 41 ± 11 
 
Table 2.  Local extension by pathological examination and tumor location based upon embryology 
 Local extension by pathologic examination [No. (%)] 
Location(No.) S RP PVS A DU CH PL 
V (21) 6 (29%) 20 (95%) 13 (62%) 5 (24%) 9 (43%) 14 (67%) 17(81%) 
D (6) 4 (67%) 2 (33%) 2 (33%) 2 (33%) 5 (83%) 5 (83%) 3(50%) 
VD (31) 20 (65%) 28 (90%) 27 (87%) 12 (39%) 22 (71%) 14 (45%) 26 (84%) 
Total (58) 30 (52%) 50 (86%) 42 (72%) 19 (33%) 36 (62%) 43 (74%) 46 (79%) 
S: serosal invasion, RP: retropancreatic tissue invasion, PVS: portal venous system invasion, A: arterial system invasion, DU: 
duodenal invasion, CH: distal bile duct invasion, PL: extra pancreatic nerve plexus invasion. 
 
Table 3.  The relationship between lymph node metastases and tumor location based upon embryology 
 Lymph nodes metastases [No (%)] 
Location (No.) N0 N1 N2 N3 
V (21) 5(24%) 3(14%) 12(57%) 1(5%) 
D (6) 1(17%) 2(33%) 3(50%) 0(0%) 
VD (31) 4(13%) 3(10%) 14(45%) 10(32%) 
Total (58) 10(17%) 8(14%) 29(50%) 11(19%) 
 
Table 4.  The relationship between the stations of the Group 2 lymph node metastases and tumor location based upon 
embryology 
 Group 2 lymph nodes metastases [No. (%)] 
Location (No.) No.6 No.8 No.12 No.14 
V (21) 0(0%) 0(0%) * 0(0%) ** 11(52%) *** 
D (6) 0(0%) 2(33%) 2(33%) 0(0%) 
VD (31) 1(3%) 6(19%) 7(23%) 25(81%) 
Total (58) 1(2%) 8(14%) 9(16%) 36(62%) 
*: p = 0.043 vs. the corresponding values in D group, **: p = 0.043 vs. the corresponding values in D group, ***: p = 0.027 vs. 
the corresponding values in D group, No.6: infrapyloric lymph nodes, No.8: lymph nodes along the common hepatic artery, 
No.12: lymph nodes in the hepatoduodenal ligament, No.14: lymph nodes along the superior mesenteric vessels. 
 
in 6 cases (10%), and extended to both areas (VD) in 31 
cases (54%). The diameter of tumor were 32 ± 13, 35 ± 8, 
and 41 ± 11 mm, respectively, in the V group, D group, and 
VD group. 
 
4.2. Local extension 
The local extension of the tumor based upon the 
pathologic examination and tumor location are summarized 
in Table 2. Invasion into retropancreatic tissue (RP), the 
portal venous system (PVS), the arterial system (A), and 
the extrapancreatic nerve plexus (PL) were detected in 50 
(86%), 42 (72%), 19 (33%), and 46 (79%) cases, 
respectively. 
 
4.3. Nodal metastasis 
The median number of resected nodes was 63 
(range, 15-135). The relationship between the tumor 
location and the degree of lymph node involvement is 
summarized in Table 3. Nodal metastases were found in 48 
cases (83%). There were 8 (14%) N1 (metastasis limited to 
Group 1 lymph nodes) cases, 29 (50%) N2 (metastasis 
limited to Group 2 lymph nodes) cases, and 11 (19%) N3 
(metastasis to Group 3 lymph nodes) cases. The 
relationship between the tumor location and the stations of 
the Group 2 lymph node metastases are shown in Table 4. 
No. 8 and No. 12 lymph nodes metastases were detected in 
D group tumors, but not in V group tumors (p = 0.043, p = 
0.043). On the other hand, No.14 lymph node metastases 
were detected in V group tumors, but not in D group 
tumors (p = 0.027). There is a statistically close 
relationship between the tumor location and No. 8, No. 12, 
and No.14 lymph nodes metastases. In the VD group, there 





The pancreas arises embryologically from two 
distinct anlagen. Both anlagen fuse at about the 6-7th fetal 
week. After fusion, it appears and functions as one mature 
organ. In the adult pancreas, the body and tail are derived 
from the dorsal pancreas, and the embryological origin of 
the head is complex. However, previous studies advocated 
that it is possible to discriminate between the ventral 
pancreas domain and the dorsal pancreas domain, because 
the shape of the islet, the percentage of fat, and the 
distribution of PP producing cells are different from each 
other (11-13, 15). Generally, the superior anterior portions 
around the duct of Santorini are derived from the dorsal 
pancreas, and the inferior dorsal portions around the duct of 
Wirsung, including the uncinate process, are derived from 
the ventral pancreas. The PV ends up between the ventral 
pancreas and dorsal pancreas by their rotation and fusion. 
The circumference of the lower bile duct is composed of 
Lymphatic spread of the carcinoma of the pancreas 
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the ventral pancreas. Therefore, we distinguished the 
ventral pancreas from the dorsal pancreas using the duct of 
Santorini, the duct of Wirsung, the PV, and the bile duct as 
landmarks. It corresponds with the identification of the 
ventral and dorsal pancreas by immunostaining for PP in 
the adult pancreas. Moreover, the boundary of the ventral and 
dorsal pancreas nearly corresponds to the line linking the 
PV/SMV and the anterior edge of the intrapancreatic bile duct. 
Based on this result, we investigated the tumor location based 
upon this embryological consideration in 58 patients with 
pancreatic head cancer who were resected in our institute. 
In twenty-one cases (36%) tumors were localized to the 
ventral pancreas, in 6 cases (10%) tumors were localized to 
the dorsal pancreas, and in 31 cases (53%) the tumors 
extended into both areas. The frequency of tumors 
localized to only the dorsal pancreas was relatively low in 
our series. This may have been due to the relatively small 
volume of the dorsal pancreas in the pancreas head, leading 
to a low incidence of pancreas head cancer in this area. 
Moreover, the CHA and hepatoduodenal ligament are close 
to the dorsal pancreas and these are easily involved with 
tumor, so surgical treatment with curative intent would be 
difficult in many cases. 
 
 The lymphatic pathways in pancreas cancer have been 
studied by many investigators. According to Hagihara's 
radioisotope study (16), two routes of lymphatic drainage 
were observed: 1. a pathway from the pancreas head to the 
lymph nodes around the celiac axis, and 2. a pathway to the 
lymph nodes around the SMA. Nagai (17) reported that dye 
injected into the posterior region of the pancreas head 
drained toward the right or posterior side of the SMA and 
finally to the para-aortic lymph nodes. According to the 
study by Deki and Sato (18), three major pathways were 
identified on the anterior surface of the head of the 
pancreas: the upper pathway belonged to the common 
hepatic group, while the middle and lower routes were 
associated with the superior mesenteric nodal group. Our 
previous study (2) found that there were four patterns of 
combinations with statistically significant relationships: 
No.13 - No.14; No.14 - No.16; No.17 - No.8; No.13 - 
No.17, and that the lymphatic flow proceeds as follows: 
pancreas head → No.14 → No.16. Thus, some patterns of 
the lymphatic spread of pancreas head carcinoma have 
already been elucidated, but none have analyzed the 
relationship between tumor location and lymphatic spread 
that might permit optimal lymph node dissection. 
In the Classification of Pancreatic Carcinoma (second 
English Edition) (14), the lymph nodes removed in a 
conventional resection are categorized as Group 1, and the 
other lymph nodes are categorized into Group 2 and 3 
depending on lymph flow, lymph node metastasis rate, and 
outcome. Moreover this classification noted that Group 3 
lymph node metastases should be treated as distant 
metastases. Therefore, the treatment of Group 2 lymph 
nodes may be very important clinically (19). 
 
Four prospective randomized trials have 
compared standard pancreatoduodenectomy versus 
pancreatoduodenectomy plus extended lymphadenectomy 
for patients with potentially curative pancreatic head 
adenocarcinoma (5, 7-9). All were unable to detect an 
improvement in survival for the more radical operation. 
Consequently many surgeons are uncertain as to how to 
treat patients with positive lymph nodes and peripancreatic 
soft tissue invasion. This question relates to the adequacy 
of the lymph node dissection and peripancreatic soft tissue 
resection, and how many lymph nodes should now be 
resected to ensure that there is adequate stage assignment. 
 
 In this study, we analyzed the sites of Group 2 
lymph node metastases of the pancreas head carcinoma as 
it correlated with the two pancreatic anlagen. We noticed 
that the lymphatic spread pattern could be attributed to 
tumor location and we speculated that this phenomenon is 
correlated with the embryological structure of pancreas. 
When the tumor is confined to the ventral pancreas domain, 
lymph node metastases are limited to areas along the SMA. 
When the tumor is confined to the dorsal pancreas domain, 
the lymph node metastases are limited to areas along the 
CHA and the hepatoduodenal ligament. However, in the 
case of cancers which extended into both domains, the 
lymph node metastases were distributed widely in areas 
along the SMA, CHA, and the hepatoduodenal ligament. 
These results indicate that lymphatic spread of the 
embryological ventral and dorsal domains of pancreas head 
carcinomas may be independent of each other even after 
the fusion of these domains. 
 
 For the purpose of adequately resection the 
tumors, the area of resection should be guided by the tumor 
location. The targeting of the resection area would be 
expected to reduce surgical morbidity such as 
intraoperative blood loss volume and operative times, as 
well as the attenuation of quality-of-life. Therefore the 
tumor location could be assessed preoperatively, "i.e., is the 
tumor localized to the ventral pancreas, the dorsal pancreas 
or both areas this can be assessed using imaging studies 
such as MD-CT, Magnetic resonance imaging (MRI), or 
endoscopic retrograde pancreatography (ERP) and 
anatomical structures such as the duct of Santorini, the duct 
of Wirsung, the PV, and the bile duct as landmarks. In the 
case of tumors confined to the ventral pancreas, the area of 
resection should be focused along the SMA, while tumors 
confined to the dorsal pancreas, the area of resection should 
be concentrated along the CHA and around the 
hepatoduodenal ligament. If a tumor extends to both areas, 
dissection including along the SMA, along the CHA and in 
the hepatoduodenal ligament is recommended. Therefore, 
the cases of dorsal pancreas were small in this series by 
aforementioned reason; the additional prospective studies 
are advancing to confirm these results. 
 
The incidence of No.6 lymph node involvement is 
not high in pancreatic cancer (2): there is only one case of 
No.6 lymph node involvement in our series in a patient 
with a tumor involving both areas. Generally, pylorus 
preservation is maintained in pancreatoduodenectomy for 
pancreas head cancer without direct invasion to the vicinity 
of the pyloric ring and No.6 lymph node involvement. The 
pyloric ring exist closely and adherent to the superior 
anterior portions of the pancreatic head which are derived 
from the dorsal pancreas. Therefore, pylorus-preserving 
pancreatoduodenectomy is a good choice for cancer limited 
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to the ventral pancreas domain. Pylorus preservation 
contributes to reducing surgical morbidity in comparison 
with a conventional pancreatoduodenectomy with a partial 




Lymphatic spread of the pancreas head 
carcinomas can be divided into two patterns based upon an 
embryological division of the pancreas and the tumor's 
location. These phenomena indicate that the adequacy of 
lymph node dissection in pancreas head carcinoma might 
be dependent upon a tumor's location based on the 
embryology of the head of the pancreas. The dissection 
area should be guided by the tumor location in order to 
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